CONDITION

Liver Disease in Dogs

Liver disease describes any condition in which the liver is not working as it should. The liver processes nutrients, filters waste from the blood, produces proteins needed for clotting, and stores energy. When it is damaged or failing, these functions can be disrupted in ways that affect the whole body. Owners often arrive at this page because their dog has become quieter than usual, is eating less, has lost weight, or has developed vomiting or diarrhoea. Some notice a yellow tinge to the gums or whites of the eyes, or that their dog is drinking and urinating more than normal. In many cases, the possibility of liver involvement emerges after blood tests taken for another reason. This page explores what liver disease can look like in dogs, what may be happening inside the liver itself, how the condition is investigated through blood work and imaging, and the range of approaches that may be considered depending on the underlying cause and stage.

Why this matters now

Liver disease in dogs can present at virtually any age, though certain forms may be more commonly recognised in middle-aged to older dogs. By the time changes are noticed, the process may have been developing for weeks or months. Some breeds carry genetic predispositions to copper storage disorders or other hepatopathies, which can influence the age at which signs first emerge. Exposure to certain toxins, medications, or infectious agents can also trigger hepatic damage at any life stage.

The trajectory of liver disease varies considerably depending on the underlying cause. Acute liver injury, for example from toxins such as xylitol or blue-green algae, or from infection such as leptospirosis, can cause an abrupt and critical loss of liver function over a matter of days, with jaundice, clotting failure, low blood glucose and hepatic encephalopathy. Chronic hepatopathies, by contrast, can develop insidiously over months or years, and early in the process subtle changes in appetite or energy may be the only indicators. As functional reserve diminishes, more overt signs such as jaundice, fluid accumulation in the abdomen, or changes in behaviour may emerge. In some cases, the condition may stabilise or even improve with appropriate management, while in others, progressive fibrosis can lead to cirrhosis and irreversible loss of function.

Signals & patterns

Early signals

Intermittent appetite reduction

Dogs with early hepatic compromise may show fluctuating interest in food, eating well on some days and refusing meals on others. This pattern can be easily attributed to fussiness or dietary boredom rather than an underlying metabolic process.

Subtle lethargy

A gradual decline in energy or enthusiasm for activities may be among the first changes noticed. Because the shift can be incremental, it may initially be interpreted as normal ageing or a response to weather or routine changes.

Occasional vomiting

Intermittent episodes of vomiting, sometimes containing bile, can occur as hepatic function begins to falter. These episodes may be sporadic enough to be put down to a minor stomach upset.

Increased water intake

Some dogs with liver involvement may begin drinking more water than usual. This change can be subtle and is sometimes only noticed when water bowls empty more quickly than expected.

Later signals

Jaundice

A yellow discolouration of the gums, whites of the eyes, or inner ear flaps indicates that bilirubin is accumulating in the bloodstream due to impaired hepatic processing. This is often one of the more recognisable signs of significant liver compromise.

Abdominal distension

Fluid accumulation in the abdominal cavity (ascites) can develop when the liver can no longer produce adequate albumin or when portal blood pressure increases. The abdomen may appear swollen or feel taut.

Behavioural changes

Hepatic encephalopathy, a consequence of the liver's reduced ability to clear toxins from the bloodstream, can show as disorientation, aimless wandering, head pressing, or altered responsiveness. These neurological signs may wax and wane, and severe episodes can progress to collapse, seizures and coma.

Weight loss despite maintained intake

Progressive loss of body condition even when appetite appears reasonable can reflect the liver's diminished capacity to process and store nutrients effectively.

Bleeding and clotting problems

Severe liver disease can reduce production of clotting factors and cause clotting problems. Bleeding into the abdomen or chest from this cause may not be visible from the outside and can cause sudden collapse. Clotting function can only be judged with blood tests.

Click to read about the biological mechanisms

How this is usually investigated

Investigating liver disease typically involves a layered approach, beginning with blood work and progressing to imaging and sometimes tissue sampling. The liver's involvement in so many metabolic processes means that a combination of tests often provides the most complete picture of what may be occurring.

Biochemistry panel

Purpose: Measures liver enzymes (ALT, ALP, GGT, AST) and functional markers (albumin, bilirubin, glucose, cholesterol, bile acids) to assess both hepatocellular damage and the liver's synthetic and excretory capacity.
Considerations: Elevated enzymes indicate damage to hepatocytes or biliary structures, but do not specify the cause. Functional markers such as albumin and bile acids provide information about the liver's remaining capacity rather than just the presence of injury.

Bile acid stimulation test

Purpose: Evaluates the liver's ability to extract bile acids from the portal circulation, providing a sensitive measure of hepatic function and portal blood flow.
Considerations: This test involves measuring bile acid levels before and after a meal, requiring two blood samples. It can be particularly useful when routine biochemistry values are only mildly altered but hepatic dysfunction is suspected.

Abdominal ultrasound

Purpose: Allows visualisation of liver size, shape, texture, and blood flow patterns, and can identify focal lesions, diffuse changes, or the presence of free abdominal fluid.
Considerations: Ultrasound can guide the clinician towards the most appropriate next steps, though some hepatic conditions produce minimal ultrasonographic changes. The presence of ascites, altered echogenicity, or vascular anomalies can help narrow the list of possible causes.

Liver biopsy

Purpose: Provides a tissue sample for histopathological examination, enabling identification of the specific type of hepatic disease, the degree of inflammation, fibrosis, or copper accumulation.
Considerations: Biopsy may be obtained via ultrasound-guided needle, laparoscopy, or surgery. Coagulation testing is typically performed beforehand, as the liver's role in producing clotting factors means that bleeding risk may be elevated in dogs with hepatic disease.

Coagulation profile

Purpose: Assesses the production of clotting factors, which are synthesised by the liver. Prolonged clotting times may indicate significant loss of hepatic synthetic function.
Considerations: This test is important both as a diagnostic indicator and as a safety measure before invasive procedures. Multiple clotting pathways may be affected when hepatic function is substantially compromised.

Options & trade-offs

Management of liver disease in dogs depends heavily on the underlying cause, the degree of hepatic compromise, and the individual dog's response. A range of approaches may be considered, and these are often combined and adjusted over time as the clinical picture evolves.

Dietary modification

Nutritional management may involve adjusting protein quantity and quality, increasing easily digestible carbohydrates, and supplementing with specific nutrients that support hepatic function. The goal is to reduce the metabolic burden on the liver while maintaining adequate nutrition.

Trade-offs: Highly restricted protein diets can lead to muscle wasting if not carefully balanced. Palatability may be reduced, which is challenging in dogs with already diminished appetites. Regular monitoring helps ensure nutritional needs are being met while supporting hepatic function.

Medications targeting the underlying cause

Depending on the specific diagnosis, various medications may be used. These can include anti-inflammatory or immunosuppressive drugs for immune-mediated hepatitis, copper chelators for copper storage disease, or antimicrobials for infectious causes.

Trade-offs: Many medications are themselves processed by the liver, requiring careful dose adjustment and monitoring. Some treatments may need to be maintained long-term, with periodic blood work to assess both therapeutic response and any medication-related effects on hepatic function.

Hepatoprotective agents

Agents such as S-adenosylmethionine (SAMe), silybin, ursodeoxycholic acid, and vitamin E are often incorporated into management protocols. SAMe, silybin and vitamin E are given as supplements, not authorised medicines. Ursodeoxycholic acid is a human medicine with no UK veterinary authorisation, so it is used in dogs under the veterinary medicines cascade. These may support hepatocyte membrane stability, promote glutathione production, or improve bile flow.

Trade-offs: Evidence for efficacy varies among these agents, and they are generally used as adjuncts rather than primary treatments. Cost can accumulate with long-term use, and individual responses may vary.

Fluid management and supportive care

Dogs with advanced liver disease may require fluid therapy to maintain hydration, electrolyte balance, and blood glucose levels. Management of ascites through dietary sodium restriction, diuretics, or therapeutic drainage may also be necessary.

Trade-offs: Aggressive fluid therapy can worsen ascites if albumin levels are very low. Repeated abdominal drainage carries risks of protein loss and infection. Balancing hydration with fluid accumulation requires careful ongoing assessment.

Management of hepatic encephalopathy

When neurological signs develop due to circulating toxins, strategies may include lactulose to reduce ammonia absorption from the gut (UK-authorised for dogs and cats for constipation, not for this use, so used here under the veterinary medicines cascade), dietary protein modification, and antimicrobials to alter gut bacterial populations.

Trade-offs: Managing encephalopathy often requires a multi-pronged approach, and signs may fluctuate despite treatment. Dietary protein must be balanced carefully: too little can worsen muscle condition, while too much may exacerbate neurological signs.

Common misconceptions

Misconception:

"Elevated liver enzymes always mean the liver is failing"

Reality:

Liver enzyme elevations indicate that hepatocytes or biliary structures are being damaged or stressed, but they do not directly measure the liver's functional capacity. A dog can have significantly elevated enzymes while the liver still functions adequately, because the organ has substantial reserve. Conversely, in end-stage liver disease, enzymes may be only mildly elevated because there are fewer remaining hepatocytes to release them. Functional tests such as bile acids and albumin levels provide more meaningful information about how well the liver is actually performing its roles.

Misconception:

"Liver disease is always caused by toxin exposure"

Reality:

While toxic injury is one cause of liver disease, many other mechanisms can be involved. Immune-mediated hepatitis, copper storage disease, infectious agents, neoplasia, and metabolic disorders can all lead to hepatic compromise. In some cases, the underlying cause remains undetermined even after thorough investigation. Assuming toxin exposure as the default cause can delay identification of the actual process at work.

Misconception:

"Once the liver is damaged, it cannot recover"

Reality:

The liver has a remarkable capacity for regeneration that is unmatched by most other organs. If the underlying cause of damage is identified and addressed before extensive fibrosis or cirrhosis develops, significant functional recovery is possible. Even dogs with substantial hepatic compromise can sometimes regain considerable function with appropriate management. However, this regenerative capacity does have limits, and chronic, ongoing injury can eventually exhaust the liver's ability to repair itself.

Related conditions

Pancreatitis in Dogs

Pancreatitis and liver disease can occur together, particularly in dogs with metabolic or inflammatory conditions affecting multiple abdominal organs. Inflammation in one organ may influence the function of neighbouring structures, and both conditions can present with overlapping signs such as vomiting, reduced appetite, and abdominal discomfort.

Cushings Disease in Dogs

Cushing's disease and liver disease may be linked through the effects of prolonged excess cortisol on liver metabolism and structure. Dogs with Cushing's often develop changes in liver enzyme levels and liver enlargement, which can complicate the interpretation of blood tests and imaging when liver disease is also suspected.

Diabetes Mellitus in Dogs

Diabetes mellitus commonly causes an enlarged liver in dogs, because fat mobilised from body stores builds up in the liver, and this can raise the question of liver disease on blood tests and imaging. Liver dysfunction caused by diabetes itself is rare. Both conditions can involve similar signs such as increased thirst, urination, and weight changes.

The page on this condition is being checked again and is offline for now.

Chronic Kidney Disease in Dogs

Chronic kidney disease and liver disease may co-exist in older dogs, and both involve progressive loss of organ function that affects waste processing and metabolic balance. The overlap in clinical signs, such as reduced appetite, weight loss, and changes in drinking and urination, can make it difficult to attribute changes to one organ system alone without blood work and imaging.

Haemangiosarcoma

Haemangiosarcoma can arise in the liver itself or in the spleen, and either presentation may produce signs that overlap with other forms of liver disease, including weakness, abdominal distension, and abnormal liver blood tests. In cases where liver masses or bleeding are detected, haemangiosarcoma is one of several possible diagnoses that may be considered alongside other liver conditions.

Understanding liver disease involves appreciating both the organ's remarkable resilience and its vulnerability when that resilience is overwhelmed. The range of possible causes and the liver's central role in so many bodily processes mean that each case may present differently and follow its own trajectory. Observations about appetite, energy, and behavioural patterns can all contribute to building a picture of how a dog's liver health may be evolving over time. The interplay between the specific underlying cause, the degree of remaining hepatic reserve, and the individual dog's overall health all influence the path forward.

Last reviewed: 9 October 2026 · Dr Alastair Greenway MRCVS